[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368420-105":59,"doc-detail-368420-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","wgcnaml-mr-integration-uncovering-immune-related-genes-in-prostate-cancer","WGCNAML-MR integration - uncovering immune-related genes in prostate cancer","","Prostate cancer continues to rise in incidence and mortality, and prostate-specific antigen (PSA) screening suffers from limited specificity, driving the need for reliable diagnostic biomarkers. This original research integrates GEO-derived differentially expressed genes with weighted gene co-expression network analysis to identify driver genes, then overlaps these sets for functional enrichment. Machine learning builds and externally validates a diagnostic model, while immune infiltration correlation and Mendelian randomization refine immune-linked biomarkers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/wgcnaml-mr-integration-uncovering-immune-related-genes-in-prostate-cancer/368420/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/wgcnaml-mr-integration-uncovering-immune-related-genes-in-prostate-cancer/368420.png","ImageObject",300,407,{"name":92,"@type":93},"Rhys","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in prostate cancer diagnosis?","Question",{"text":112,"@type":113},"PSA screening is widely used but lacks specificity, contributing to overdiagnosis and overtreatment. The study targets this gap by searching for new diagnostic biomarkers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were candidate biomarkers identified?",{"text":117,"@type":113},"Datasets from GEO were used to screen differentially expressed genes, WGCNA identified driver genes linked to prostate cancer modules, and the intersection was tested by KEGG/GO enrichment. Machine learning then selected core genes and built a diagnostic model with external validation.",{"name":119,"@type":110,"acceptedAnswer":120},"What key biomarkers were reported and what does the MR analysis suggest?",{"text":121,"@type":113},"Six core biomarkers were identified: SLC14A1, ARHGEF38, NEFH, MSMB, KRT23, and KRT15. Mendelian randomization indicated that MSMB may be an important protective factor for prostate cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368420,1790240224,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","TYPE Original Research PUBLISHED 07 April 2025  \nDOI 10.3389/fonc.2025.1534612  \nOPEN ACCESS  \nEDITED BY  \nNemat Ali,  \nKing Saud University, Saudi Arabia  \nREVIEWED BY  \nPravin Hivare,  \nThe University of Utah, United States Elad Mazor,  \nSoroka Medical Center, Israel  \n*CORRESPONDENCE  \nNinghan Feng  \n [n.feng@jiangnan.edu.cn](n.feng@jiangnan.edu.cn)[ ](n.feng@jiangnan.edu.cn)Yuwei Zhang  \n [zhangyw0123@njmu.edu.cn](zhangyw0123@njmu.edu.cn)[ ](zhangyw0123@njmu.edu.cn)Menglu Li  \n [lmlbw1232@163.com](lmlbw1232@163.com)  \n†These authors have contributed equally to this work  \nRECEIVED 26 November 2024  \nACCEPTED 21 March 2025  \nPUBLISHED 07 April 2025  \nCITATION  \nLv J, Zhou Y, Jin S, Fu C, Shen Y, Liu B, Li M, Zhang Y and Feng N (2025) WGCNAML-MR integration: uncovering immunerelated genes in prostate cancer.  \nFront. Oncol. 15:1534612 .  \ndoi: 10.3389/fonc.2025.1534612  \nCOPYRIGHT  \n© 2025 Lv, Zhou, Jin, Fu, Shen, Liu, Li, Zhang and Feng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nWGCNA-ML-MR integration: uncovering immune-related genes in prostate cancer  \nJing Lv 1,2†, Yuhua Zhou 1,2†, Shengkai Jin 1,2†, Chaowei Fu 1,2, Yang Shen 2,3, Bo Liu 2,4, Menglu Li 2*, Yuwei Zhang 2,4* and Ninghan Feng 1,2,4*  \n1Wuxi School of Medicine, Jiangnan University, Wuxi, China, 2 Department of Urology, Jiangnan University Medical Center, Wuxi, China, 3 Department of Clinical Medicine, Nanjing Medical University, Nanjing, China, 4 Department of Clinical Medicine, Nantong University Medical School,  \nNantong, China  \nBackground: Prostate cancer is one of the most common tumors in men, with its incidence and mortality rates continuing to rise year by year. Prostate-speciﬁc antigen (PSA) is the most commonly used screening indicator, but its lack of speciﬁcity leads to overdiagnosis and overtreatment. Therefore, identifying new biomarkers related to prostate cancer is crucial for the early diagnosis and treatment of prostate cancer.  \nMethods: This study utilized datasets from the Gene Expression Omnibus (GEO) to screen for differentially expressed genes (DEGs) and employed Weighted Gene Co-expression Network Analysis (WGCNA) to identify driver genes highly associated with prostate cancer within the modules . The intersection of differentially expressed genes and driver genes was taken, and Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment analyses were performed. Furthermore, a machine learning algorithm was used to screen for core genes and construct a diagnostic model, which was then validated in an external validation dataset. The correlation between core genes and immune cell inﬁltration was analyzed, and Mendelian randomization (MR) analysis was conducted to identify biomarkers closely related to prostate cancer.  \nResults: This study identiﬁed six core biomarkers: SLC14A1, ARHGEF38, NEFH, MSMB, KRT23, and KRT15 . MR analysis demonstrated that MSMB may be an important protective factor for prostate cancer . In q-PCR experiments conducted on tumor tissues and adjacent non-cancerous tissues from prostate cancer patients, it was found that: compared to the adjacent noncancerous tissues, the expression level of ARHGEF38 in prostate cancer tumor tissues signiﬁcantly increased, while the expression levels of SLC14A1, NEFH, MSMB, KRT23, and KRT15 signiﬁcantly decreased. To further validate these ﬁndings at the protein level, we conducted Western blot analysis, which corroborated the q-PCR results, demonstrating consistent expression patterns for all six biomarkers. IHC results conﬁrmed that ARHGEF38 protein was h","cbCaicOwrFnjcBD0","https://ap.wps.com/l/cbCaicOwrFnjcBD0","pdf",19908450,18,"English","# Background\n## Methods\n## Results\n## Conclusion","[{\"question\":\"What problem does the study address in prostate cancer diagnosis?\",\"answer\":\"PSA screening is widely used but lacks specificity, contributing to overdiagnosis and overtreatment. The study targets this gap by searching for new diagnostic biomarkers.\"},{\"question\":\"How were candidate biomarkers identified?\",\"answer\":\"Datasets from GEO were used to screen differentially expressed genes, WGCNA identified driver genes linked to prostate cancer modules, and the intersection was tested by KEGG/GO enrichment. Machine learning then selected core genes and built a diagnostic model with external validation.\"},{\"question\":\"What key biomarkers were reported and what does the MR analysis suggest?\",\"answer\":\"Six core biomarkers were identified: SLC14A1, ARHGEF38, NEFH, MSMB, KRT23, and KRT15. Mendelian randomization indicated that MSMB may be an important protective factor for prostate cancer.\"}]","WGCNAML-MR integration - uncovering immune-related genes in prostate cancer | PDF",1790176875,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3aafae22056d0a9467fa7a0c8b4a058.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d236ab173290098cc953df265c4ca875.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54c78a5c43c30b40093faa89332c468b.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b4c40c62fc6bf4bf220ca4395a9cf68.webp",980,1385]